[
  {
    "title": "昂利康总经理蒋震山辞职 郑国钢接任 2022年前三季度公司净利1.08亿",
    "href": "http://stock.jrj.com.cn/2023/01/05195237262308.shtml",
    "datetime": "2023-01-05 19:52:20",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：董事、总经理蒋震山辞职 郑国钢接任",
    "href": "http://stock.jrj.com.cn/2023/01/05173137261755.shtml",
    "datetime": "2023-01-05 17:31:06",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：“年产21.7亿片(粒、支、袋)制剂生产基地建设项目(一期)”结项",
    "href": "http://stock.jrj.com.cn/2022/11/29220737176008.shtml",
    "datetime": "2022-11-29 22:07:43",
    "code": "002940"
  },
  {
    "title": "A股异动 | 昂利康续跌5% 股东拟减持不超0.54%股份",
    "href": "http://stock.jrj.com.cn/2022/11/23104537159910.shtml",
    "datetime": "2022-11-23 10:45:35",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：吴伟华拟清仓减持不超0.54%股份",
    "href": "http://stock.jrj.com.cn/2022/11/21165837154520.shtml",
    "datetime": "2022-11-21 16:58:46",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)2022年半年度权益分派10转4.5股 股权登记日11月14日",
    "href": "http://stock.jrj.com.cn/2022/11/07171437117501.shtml",
    "datetime": "2022-11-07 17:14:28",
    "code": "002940"
  },
  {
    "title": "昂利康2022年前三季度净利1.08亿同比增长44% 原料药业务毛利增加",
    "href": "http://stock.jrj.com.cn/2022/10/24213237079644.shtml",
    "datetime": "2022-10-24 21:32:34",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)三季度净利2917.12万元 同比增长203.43%",
    "href": "http://stock.jrj.com.cn/2022/10/24175937078622.shtml",
    "datetime": "2022-10-24 17:59:10",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟变更为以现金收购科瑞生物38.22%股份",
    "href": "http://stock.jrj.com.cn/2022/10/11202237048168.shtml",
    "datetime": "2022-10-11 20:22:13",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：铝碳酸镁咀嚼片(0.5g)通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/10/09174237041932.shtml",
    "datetime": "2022-10-09 17:42:56",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)上半年净利同比增长20.62% 拟10转4.5股",
    "href": "http://stock.jrj.com.cn/2022/08/30170536953098.shtml",
    "datetime": "2022-08-30 17:05:23",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟向嵊州市慈善总会捐赠500万元，捐期5年",
    "href": "http://stock.jrj.com.cn/2022/07/21173636832469.shtml",
    "datetime": "2022-07-21 17:36:43",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：头孢克肟胶囊拟中选第七批国采",
    "href": "http://stock.jrj.com.cn/2022/07/13183236808236.shtml",
    "datetime": "2022-07-13 18:32:45",
    "code": "002940"
  },
  {
    "title": "科瑞生物股东甘红星质押2589.6万股 用于担保甘红星对浙江昂利康制药所支付购买股份意向金的返还义务",
    "href": "http://stock.jrj.com.cn/2022/07/11223136800810.shtml",
    "datetime": "2022-07-11 22:31:45",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)放弃湖南新合新生物医药增资优先认购权",
    "href": "http://stock.jrj.com.cn/2022/06/26165636759248.shtml",
    "datetime": "2022-06-26 16:56:23",
    "code": "002940"
  },
  {
    "title": "昂利康控股股东嵊州君泰质押350万股 用于经营所需",
    "href": "http://stock.jrj.com.cn/2022/06/20205236744246.shtml",
    "datetime": "2022-06-20 20:52:47",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)2021年度权益分派10派3元 股权登记日为6月17日",
    "href": "http://stock.jrj.com.cn/2022/06/09171936716248.shtml",
    "datetime": "2022-06-09 17:19:39",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：头孢克肟胶囊(100mg)通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/05/25170936677901.shtml",
    "datetime": "2022-05-25 17:09:46",
    "code": "002940"
  },
  {
    "title": "昂利康控股股东嵊州君泰质押350万股 用于经营所需",
    "href": "http://stock.jrj.com.cn/2022/05/20191036666801.shtml",
    "datetime": "2022-05-20 19:10:49",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：控股股东质押350万股",
    "href": "http://stock.jrj.com.cn/2022/05/20165336666063.shtml",
    "datetime": "2022-05-20 16:53:52",
    "code": "002940"
  },
  {
    "title": "昂利康：与科瑞生物签署《技术转让（技术秘密）合同》并组建合资公司",
    "href": "http://stock.jrj.com.cn/2022/05/12121736642334.shtml",
    "datetime": "2022-05-12 12:17:39",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟与科瑞生物共同受让“新型药物递送系统及制备方法”的技术成果并组建合资公司",
    "href": "http://stock.jrj.com.cn/2022/05/11190336635542.shtml",
    "datetime": "2022-05-11 19:03:25",
    "code": "002940"
  },
  {
    "title": "昂利康2022年第一季度净利3908.65万 同比增长19.23%",
    "href": "http://stock.jrj.com.cn/2022/05/03205136547799.shtml",
    "datetime": "2022-05-03 20:51:03",
    "code": "002940"
  },
  {
    "title": "昂利康2021年净利1.2亿同比减少26.8% 董事长方南平薪酬80.21万",
    "href": "http://stock.jrj.com.cn/2022/04/16051336350646.shtml",
    "datetime": "2022-04-16 05:13:01",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：2021年净利降26.80%至1.2亿元 拟10派3元",
    "href": "http://stock.jrj.com.cn/2022/04/15195736346769.shtml",
    "datetime": "2022-04-15 19:57:51",
    "code": "002940"
  },
  {
    "title": "昂利康拟购买科瑞生物61%股权 股票复牌",
    "href": "http://stock.jrj.com.cn/2022/04/12225836318158.shtml",
    "datetime": "2022-04-12 22:58:48",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)拟收购科瑞生物61%股权 明起复牌",
    "href": "http://stock.jrj.com.cn/2022/04/12203636317210.shtml",
    "datetime": "2022-04-12 20:36:43",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟推第一期员工持股计划",
    "href": "http://stock.jrj.com.cn/2022/04/11205436307868.shtml",
    "datetime": "2022-04-11 20:54:28",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：监事潘小云提前终止减持计划 未减持公司股份",
    "href": "http://stock.jrj.com.cn/2022/04/06165936263084.shtml",
    "datetime": "2022-04-06 16:59:12",
    "code": "002940"
  },
  {
    "title": "昂利康：拟收购科瑞生物控股权 3月28日股票停牌",
    "href": "http://stock.jrj.com.cn/2022/03/28102235812788.shtml",
    "datetime": "2022-03-28 10:22:51",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)拟发行股份收购科瑞生物控股权 明起停牌",
    "href": "http://stock.jrj.com.cn/2022/03/27175235597263.shtml",
    "datetime": "2022-03-27 17:52:33",
    "code": "002940"
  },
  {
    "title": "A股异动 | 昂利康涨超9% 拟斥不超4000万元继续增持科瑞生物股份",
    "href": "http://stock.jrj.com.cn/2022/03/25112035067300.shtml",
    "datetime": "2022-03-25 11:20:08",
    "code": "002940"
  },
  {
    "title": "昂利康以自有资金1350.09万增持科瑞生物1.35%股份 2021年公司净利1.05亿",
    "href": "http://stock.jrj.com.cn/2022/03/24165234902378.shtml",
    "datetime": "2022-03-24 16:52:08",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟斥不超4000万元继续增持科瑞生物(832780.OC)股份",
    "href": "http://stock.jrj.com.cn/2022/03/23181434870332.shtml",
    "datetime": "2022-03-23 18:14:58",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：替格瑞洛片获批上市",
    "href": "http://stock.jrj.com.cn/2022/03/09164234556758.shtml",
    "datetime": "2022-03-09 16:42:44",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：苯磺酸左氨氯地平片未中选浙江省带量采购",
    "href": "http://stock.jrj.com.cn/2022/03/02183034513048.shtml",
    "datetime": "2022-03-02 18:30:01",
    "code": "002940"
  },
  {
    "title": "科瑞生物股东海南盛健医药科技减持1125.64万股 股东浙江昂利康制药增持1125.64万股",
    "href": "http://stock.jrj.com.cn/2022/02/21213234424017.shtml",
    "datetime": "2022-02-21 21:32:47",
    "code": "002940"
  },
  {
    "title": "昂利康聘任罗金文为公司副总经理 2021年第三季度公司净利961.38万",
    "href": "http://stock.jrj.com.cn/2022/02/18205034398118.shtml",
    "datetime": "2022-02-18 20:50:44",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟1.57亿元增持科瑞生物(832780.OC)15.74%股份",
    "href": "http://stock.jrj.com.cn/2022/02/18174534392767.shtml",
    "datetime": "2022-02-18 17:45:41",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟以2亿元受让新合新18.19%股权",
    "href": "http://stock.jrj.com.cn/2022/01/28205234248646.shtml",
    "datetime": "2022-01-28 20:52:33",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：异氟烷原料药通过药品GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2022/01/25180334213083.shtml",
    "datetime": "2022-01-25 18:03:48",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：完成回购 已累计回购2.15%股份",
    "href": "http://stock.jrj.com.cn/2022/01/21214334184390.shtml",
    "datetime": "2022-01-21 21:43:27",
    "code": "002940"
  },
  {
    "title": "昂利康：异氟烷原料药通过CDE审批",
    "href": "http://stock.jrj.com.cn/2022/01/20170534178874.shtml",
    "datetime": "2022-01-20 17:05:46",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：异氟烷原料药通过CDE审批",
    "href": "http://stock.jrj.com.cn/2022/01/20165634178811.shtml",
    "datetime": "2022-01-20 16:56:09",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：监事潘小云拟减持不超7.5万股",
    "href": "http://stock.jrj.com.cn/2021/12/10162833994779.shtml",
    "datetime": "2021-12-10 16:28:26",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：截至11月底已累计回购2.15%股份",
    "href": "http://stock.jrj.com.cn/2021/12/01204433951492.shtml",
    "datetime": "2021-12-01 20:44:04",
    "code": "002940"
  },
  {
    "title": "昂利康股东吴伟华减持24.01万股 套现约1050.35万 第三季度公司净利961.38万",
    "href": "http://stock.jrj.com.cn/2021/11/29191133939105.shtml",
    "datetime": "2021-11-29 19:11:16",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：股东吴伟华完成减持24万股",
    "href": "http://stock.jrj.com.cn/2021/11/29173533938578.shtml",
    "datetime": "2021-11-29 17:35:15",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：实控人吕慧浩解押136万股",
    "href": "http://stock.jrj.com.cn/2021/11/26165733923969.shtml",
    "datetime": "2021-11-26 16:57:32",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：控股股东质押292.5万股",
    "href": "http://stock.jrj.com.cn/2021/11/11164733836645.shtml",
    "datetime": "2021-11-11 16:47:46",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：控股股东质押352万股",
    "href": "http://stock.jrj.com.cn/2021/11/03191333809402.shtml",
    "datetime": "2021-11-03 19:13:54",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：截至10月底已累计回购2.15%股份",
    "href": "http://stock.jrj.com.cn/2021/11/01172233798645.shtml",
    "datetime": "2021-11-01 17:22:27",
    "code": "002940"
  },
  {
    "title": "昂利康：前三季度净利润7519.40万元，同比下降39.47%",
    "href": "http://stock.jrj.com.cn/2021/10/29105333775943.shtml",
    "datetime": "2021-10-29 10:53:40",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)与汉伟医疗签署战略合作协议 在医疗器械和医美领域进行合作发展",
    "href": "http://stock.jrj.com.cn/2021/10/28230633772966.shtml",
    "datetime": "2021-10-28 23:06:50",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：实控人方南平和吕慧浩续签一致行动协议",
    "href": "http://stock.jrj.com.cn/2021/10/22222833735799.shtml",
    "datetime": "2021-10-22 22:28:29",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：4275万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/10/20165033722212.shtml",
    "datetime": "2021-10-20 16:50:30",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)截至8月底已累计回购2.15%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/01164333368084.shtml",
    "datetime": "2021-09-01 16:43:06",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟出资3000万元投设合资公司 以新建宠物专用药品生产线",
    "href": "http://stock.jrj.com.cn/2021/08/20214333289619.shtml",
    "datetime": "2021-08-20 21:43:13",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：上半年净利降22.91%至6558.02万元",
    "href": "http://stock.jrj.com.cn/2021/08/20213633289584.shtml",
    "datetime": "2021-08-20 21:36:57",
    "code": "002940"
  },
  {
    "title": "昂利康2021年半年度净利6558.02万元 同比净利减少22.91%",
    "href": "http://stock.jrj.com.cn/2021/08/20212833289529.shtml",
    "datetime": "2021-08-20 21:28:15",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)截至7月30日已累计回购2.15%的股份",
    "href": "http://stock.jrj.com.cn/2021/08/02212433190816.shtml",
    "datetime": "2021-08-02 21:24:30",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟向海西药业增资4687.50万元 持股比例将增至51.82%",
    "href": "http://stock.jrj.com.cn/2021/07/20214833126147.shtml",
    "datetime": "2021-07-20 21:48:56",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)截至6月底已累计回购2.15%的股份",
    "href": "http://stock.jrj.com.cn/2021/07/01194033028758.shtml",
    "datetime": "2021-07-01 19:40:37",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟与海昶生物签订“HC008”项目的合作协议并共设合资公司",
    "href": "http://stock.jrj.com.cn/2021/06/29193033017186.shtml",
    "datetime": "2021-06-29 19:30:23",
    "code": "002940"
  },
  {
    "title": "昂利康：公司主要产品未在本次国家集中采购目录内",
    "href": "http://stock.jrj.com.cn/2021/06/24212132991726.shtml",
    "datetime": "2021-06-24 21:21:09",
    "code": "002940"
  },
  {
    "title": "昂利康：制剂一期项目预计于2021年12月底前投产",
    "href": "http://stock.jrj.com.cn/2021/06/17205632949624.shtml",
    "datetime": "2021-06-17 20:56:07",
    "code": "002940"
  },
  {
    "title": "昂利康：销售费用主要包括业务推广费等",
    "href": "http://stock.jrj.com.cn/2021/06/17205332949601.shtml",
    "datetime": "2021-06-17 20:53:40",
    "code": "002940"
  },
  {
    "title": "【龙虎榜】昂利康6月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/06/08180432894563.shtml",
    "datetime": "2021-06-08 18:04:43",
    "code": "002940"
  },
  {
    "title": "【龙虎榜】昂利康6月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/06/07180332887672.shtml",
    "datetime": "2021-06-07 18:03:52",
    "code": "002940"
  },
  {
    "title": "【龙虎榜】昂利康6月2日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/06/02180532864317.shtml",
    "datetime": "2021-06-02 18:05:02",
    "code": "002940"
  },
  {
    "title": "A股异动 | 昂利康(002940.SZ)连续第三日涨停 股价创5个月新高",
    "href": "http://stock.jrj.com.cn/2021/06/02103032861778.shtml",
    "datetime": "2021-06-02 10:30:01",
    "code": "002940"
  },
  {
    "title": "昂利康：公司出口业务占比较小",
    "href": "http://stock.jrj.com.cn/2021/05/31170732850707.shtml",
    "datetime": "2021-05-31 17:07:10",
    "code": "002940"
  },
  {
    "title": "A股异动 | 昂利康(002940.SZ)大涨近9% 拟与海昶生物就“HC008”研发生产开展合作",
    "href": "http://stock.jrj.com.cn/2021/05/31142332848876.shtml",
    "datetime": "2021-05-31 14:23:58",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)与海昶生物就\"HC008\"签订合作备忘录",
    "href": "http://stock.jrj.com.cn/2021/05/30180832841402.shtml",
    "datetime": "2021-05-30 18:08:38",
    "code": "002940"
  },
  {
    "title": "昂利康：公司的头孢克洛缓释片是目前国内唯一一家通过一致性评价的仿制药品种",
    "href": "http://stock.jrj.com.cn/2021/05/26132032822498.shtml",
    "datetime": "2021-05-26 13:20:50",
    "code": "002940"
  },
  {
    "title": "昂利康：公司尚未收到浙江海昶生物医药技术有限公司有关于科创板、创业板或者港股上市的明确计划",
    "href": "http://stock.jrj.com.cn/2021/05/26131632822485.shtml",
    "datetime": "2021-05-26 13:16:51",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：594.6819万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/05/23164032798398.shtml",
    "datetime": "2021-05-23 16:40:51",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：累计耗资6333.09万元回购2.15%股份",
    "href": "http://stock.jrj.com.cn/2021/05/18165432776614.shtml",
    "datetime": "2021-05-18 16:54:38",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：已累计回购1.29%的股份",
    "href": "http://stock.jrj.com.cn/2021/05/10171932730381.shtml",
    "datetime": "2021-05-10 17:19:21",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：股东吴伟华拟减持不超50万股",
    "href": "http://stock.jrj.com.cn/2021/05/05202532682368.shtml",
    "datetime": "2021-05-05 20:25:48",
    "code": "002940"
  },
  {
    "title": "昂利康：公司经营正常 但未对2021年度盈利做过预测",
    "href": "http://stock.jrj.com.cn/2021/04/29211232482446.shtml",
    "datetime": "2021-04-29 21:12:51",
    "code": "002940"
  },
  {
    "title": "昂利康：制剂一期项目预计于2021年12月底前投产",
    "href": "http://stock.jrj.com.cn/2021/04/28105332469851.shtml",
    "datetime": "2021-04-28 10:53:08",
    "code": "002940"
  },
  {
    "title": "昂利康：公司的业务主要为化学制剂和化学原料药 2020年度 原料药及中间体的产量为523.86吨",
    "href": "http://stock.jrj.com.cn/2021/04/28105232469845.shtml",
    "datetime": "2021-04-28 10:52:56",
    "code": "002940"
  },
  {
    "title": "昂利康跌7.64% 长信基金五矿证券或持股",
    "href": "http://stock.jrj.com.cn/2021/04/19170232402680.shtml",
    "datetime": "2021-04-19 17:02:51",
    "code": "002940"
  },
  {
    "title": "昂利康2020年净利增长45.83% 董事长方南平薪酬80.15万",
    "href": "http://stock.jrj.com.cn/2021/04/18102232392689.shtml",
    "datetime": "2021-04-18 10:22:39",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：2020年度净利升45.83%至1.64亿元 拟10派5元",
    "href": "http://stock.jrj.com.cn/2021/04/16201232388514.shtml",
    "datetime": "2021-04-16 20:12:21",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)截至3月底已累计回购51.49万股",
    "href": "http://stock.jrj.com.cn/2021/04/01214932265694.shtml",
    "datetime": "2021-04-01 21:49:45",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：3月10日首次回购691.94万元股份",
    "href": "http://stock.jrj.com.cn/2021/03/10174132104402.shtml",
    "datetime": "2021-03-10 17:41:28",
    "code": "002940"
  },
  {
    "title": "昂利康：公司年产21.7亿片制剂生产基地建设项目总投资3.3亿元 使用募集资金1.9亿元",
    "href": "http://stock.jrj.com.cn/2021/03/08152632091108.shtml",
    "datetime": "2021-03-08 15:26:48",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：截至2月底 尚未开始回购股份",
    "href": "http://stock.jrj.com.cn/2021/03/01171532051055.shtml",
    "datetime": "2021-03-01 17:15:28",
    "code": "002940"
  },
  {
    "title": "昂利康2020年度净利1.64亿增长46.19% 高毛利自有制剂产品收入稳步增长",
    "href": "http://stock.jrj.com.cn/2021/02/26223332035840.shtml",
    "datetime": "2021-02-26 22:33:08",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)业绩快报：2020年度净利润升46.19%至1.64亿元",
    "href": "http://stock.jrj.com.cn/2021/02/26192932034743.shtml",
    "datetime": "2021-02-26 19:29:44",
    "code": "002940"
  },
  {
    "title": "昂利康：公司苯磺酸左氨氯地平片一致性评价和制剂生产基地建设项目正在推进",
    "href": "http://stock.jrj.com.cn/2021/02/10185131884330.shtml",
    "datetime": "2021-02-10 18:51:16",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)拟回购5000万元-1亿元股份 回购价不超55元/股",
    "href": "http://stock.jrj.com.cn/2021/01/22211531747391.shtml",
    "datetime": "2021-01-22 21:15:41",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/01/15171131699846.shtml",
    "datetime": "2021-01-15 17:11:32",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟使用不超1.2亿元首发闲置募集资金购买银行理财产品",
    "href": "http://stock.jrj.com.cn/2021/01/06171331642247.shtml",
    "datetime": "2021-01-06 17:13:08",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：累计收到各类政府补助资金共1281.34万元",
    "href": "http://stock.jrj.com.cn/2020/12/29210731597497.shtml",
    "datetime": "2020-12-29 21:07:49",
    "code": "002940"
  },
  {
    "title": "[昂利康]2020年度浙江昂利康制药股份有限公司土壤地下水自主检测报告",
    "href": "http://stock.jrj.com.cn/2020/12/24000031561087.shtml",
    "datetime": "2020-12-24 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：收购海西药业33.80%股权的交易过户及工商登记手续已全部办理完毕",
    "href": "http://stock.jrj.com.cn/2020/12/23182231554981.shtml",
    "datetime": "2020-12-23 18:22:02",
    "code": "002940"
  },
  {
    "title": "昂利康股东吴伟华减持109.25万股 套现约5971.56万元",
    "href": "http://stock.jrj.com.cn/2020/12/18194531520454.shtml",
    "datetime": "2020-12-18 19:45:08",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：两股东减持期届满 仅吴伟华减持109.25万股",
    "href": "http://stock.jrj.com.cn/2020/12/18182931519826.shtml",
    "datetime": "2020-12-18 18:29:27",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟以4000万元参与投资嘉兴元徕",
    "href": "http://stock.jrj.com.cn/2020/12/15195531496259.shtml",
    "datetime": "2020-12-15 19:55:13",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：拟将定增募资额全部优先投入到杭州药物研发平台项目",
    "href": "http://stock.jrj.com.cn/2020/12/02215431394970.shtml",
    "datetime": "2020-12-02 21:54:21",
    "code": "002940"
  },
  {
    "title": "昂利康：拟签署股权转让协议 受让海西联合药业33.80%股权",
    "href": "http://stock.jrj.com.cn/2020/12/02204031394528.shtml",
    "datetime": "2020-12-02 20:40:43",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)披露A股定增报告书",
    "href": "http://stock.jrj.com.cn/2020/11/25220831348636.shtml",
    "datetime": "2020-11-25 22:08:28",
    "code": "002940"
  },
  {
    "title": "[昂利康]【校企合作,筑梦未来】浙江昂利康制药股份有限公司与嵊州职业教育中心校企合作签约仪式顺利举行",
    "href": "http://stock.jrj.com.cn/2020/11/21000031337513.shtml",
    "datetime": "2020-11-21 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康2020年前三季度净利1.24亿增长37.41% 其他收益同比增长",
    "href": "http://stock.jrj.com.cn/2020/10/28141731150579.shtml",
    "datetime": "2020-10-28 14:17:59",
    "code": "002940"
  },
  {
    "title": "昂利康：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/28012031145781.shtml",
    "datetime": "2020-10-28 01:20:01",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)：前三季净利升37.41%至1.24亿元",
    "href": "http://stock.jrj.com.cn/2020/10/27211531144494.shtml",
    "datetime": "2020-10-27 21:15:50",
    "code": "002940"
  },
  {
    "title": "昂利康(002940.SZ)与川宁生物签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2020/10/13201331045578.shtml",
    "datetime": "2020-10-13 20:13:36",
    "code": "002940"
  },
  {
    "title": "昂利康非公开发行股票申请获证监会审核通过",
    "href": "http://stock.jrj.com.cn/2020/08/31193430645120.shtml",
    "datetime": "2020-08-31 19:34:43",
    "code": "002940"
  },
  {
    "title": "[昂利康]关于江苏悦新药业有限公司严格对照《企业事业单位环境信息公开办法》第九条、第十条、第十一条规定",
    "href": "http://stock.jrj.com.cn/2020/08/25000030584675.shtml",
    "datetime": "2020-08-25 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]中国证监会投资者维权渠道介绍",
    "href": "http://stock.jrj.com.cn/2020/08/05000030433002.shtml",
    "datetime": "2020-08-05 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]昂利康头孢克洛缓释片国内首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/07/31000030394537.shtml",
    "datetime": "2020-07-31 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康：公司目前不生产碘海醇 现有业务与碘海醇没有关联度",
    "href": "http://stock.jrj.com.cn/2020/07/29174130374533.shtml",
    "datetime": "2020-07-29 17:41:46",
    "code": "002940"
  },
  {
    "title": "昂利康2020年上半年净利8507.16万增长30.46% 营业成本下滑",
    "href": "http://stock.jrj.com.cn/2020/07/27225030357669.shtml",
    "datetime": "2020-07-27 22:50:02",
    "code": "002940"
  },
  {
    "title": "上半年仅一款药通过一致性评价 A股“新兵”昂利康何时找回上市前“雄风”",
    "href": "http://stock.jrj.com.cn/2020/07/27084930352384.shtml",
    "datetime": "2020-07-27 08:49:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]「聚焦」实验室技能比武,昂利康人与“质量”赛跑",
    "href": "http://stock.jrj.com.cn/2020/07/03000030134904.shtml",
    "datetime": "2020-07-03 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]「聚焦」实验室技能比武,昂利康人与“质量”赛跑",
    "href": "http://stock.jrj.com.cn/2020/07/02000031824366.shtml",
    "datetime": "2020-07-02 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康2名股东拟减持股份 预计合计减持不超总股本2.14%",
    "href": "http://stock.jrj.com.cn/2020/05/26203929770351.shtml",
    "datetime": "2020-05-26 20:39:52",
    "code": "002940"
  },
  {
    "title": "昂利康监事严立勇与股东吴伟华拟减持不超过总股本2.14%",
    "href": "http://stock.jrj.com.cn/2020/05/26173129769245.shtml",
    "datetime": "2020-05-26 17:31:11",
    "code": "002940"
  },
  {
    "title": "昂利康两股东拟合计减持不超2.14%股份",
    "href": "http://stock.jrj.com.cn/2020/05/26173029769265.shtml",
    "datetime": "2020-05-26 17:30:04",
    "code": "002940"
  },
  {
    "title": "昂利康：监事严立勇与股东吴伟华拟减持不超过总股本2.14%",
    "href": "http://stock.jrj.com.cn/2020/05/26171829769155.shtml",
    "datetime": "2020-05-26 17:18:50",
    "code": "002940"
  },
  {
    "title": "[昂利康]浙江省副省长陈奕君一行莅临公司参观调研",
    "href": "http://stock.jrj.com.cn/2020/05/22000030087489.shtml",
    "datetime": "2020-05-22 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康第一季度盈利4179.38万同比增长24.36% 管理费用增加",
    "href": "http://stock.jrj.com.cn/2020/04/21212829340820.shtml",
    "datetime": "2020-04-21 21:28:09",
    "code": "002940"
  },
  {
    "title": "昂利康研发投入下滑近两成 业绩重回高增长难",
    "href": "http://stock.jrj.com.cn/2020/04/07081829245518.shtml",
    "datetime": "2020-04-07 08:18:00",
    "code": "002940"
  },
  {
    "title": "昂利康研发投入下滑近两成 业绩重回高增长难",
    "href": "http://stock.jrj.com.cn/2020/04/07081829222692.shtml",
    "datetime": "2020-04-07 08:18:00",
    "code": "002940"
  },
  {
    "title": "昂利康：2019年净利润同比增长3.29% 拟10派10",
    "href": "http://stock.jrj.com.cn/2020/04/02210229179452.shtml",
    "datetime": "2020-04-02 21:02:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]金牛报喜!昂利康连续两年荣获三项第一",
    "href": "http://stock.jrj.com.cn/2020/03/07000030087477.shtml",
    "datetime": "2020-03-07 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康2019年净利1.12亿增长3% 制剂业务收入增长所致",
    "href": "http://stock.jrj.com.cn/2020/02/28101428911996.shtml",
    "datetime": "2020-02-28 10:14:36",
    "code": "002940"
  },
  {
    "title": "[昂利康]中国证监会投资者保护局温馨提示",
    "href": "http://stock.jrj.com.cn/2020/02/28000030087483.shtml",
    "datetime": "2020-02-28 00:00:00",
    "code": "002940"
  },
  {
    "title": "上市刚满一年部分IPO项目暂缓 昂利康高管解禁首日即抛减持计划",
    "href": "http://stock.jrj.com.cn/2019/10/27071828304620.shtml",
    "datetime": "2019-10-27 07:18:01",
    "code": "002940"
  },
  {
    "title": "昂利康第三季度盈利2520万 同比增长71.32%",
    "href": "http://stock.jrj.com.cn/2019/10/26091328303546.shtml",
    "datetime": "2019-10-26 09:13:52",
    "code": "002940"
  },
  {
    "title": "昂利康：6名董监高拟合计减持不超5.21%股份",
    "href": "http://stock.jrj.com.cn/2019/10/24193128295888.shtml",
    "datetime": "2019-10-24 19:31:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]市委书记走访企业开展“三服务”活动",
    "href": "http://stock.jrj.com.cn/2019/09/04000030087467.shtml",
    "datetime": "2019-09-04 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康2019年上半年盈利6521万 子公司部分订单推迟执行",
    "href": "http://stock.jrj.com.cn/2019/08/25162628028496.shtml",
    "datetime": "2019-08-25 16:26:30",
    "code": "002940"
  },
  {
    "title": "[昂利康]省经信厅巡视员一行来嵊州开展“三服务”活动",
    "href": "http://stock.jrj.com.cn/2019/06/26000030087463.shtml",
    "datetime": "2019-06-26 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康一季度净利3361万同比增长0.2% 现金流量净额为5127万元",
    "href": "http://stock.jrj.com.cn/2019/04/29074727504747.shtml",
    "datetime": "2019-04-29 07:47:38",
    "code": "002940"
  },
  {
    "title": "昂利康去年净利1.09亿元 同比增长8% 董事长方南平年薪为60万元",
    "href": "http://stock.jrj.com.cn/2019/04/02084327304481.shtml",
    "datetime": "2019-04-02 08:43:33",
    "code": "002940"
  },
  {
    "title": "昂利康2018年度净利润同比增长7.53% 拟10派7.5元",
    "href": "http://stock.jrj.com.cn/2019/03/29213327269225.shtml",
    "datetime": "2019-03-29 21:33:56",
    "code": "002940"
  },
  {
    "title": "昂利康：拟投资1220万元设立子公司白云山昂利康",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/22080025390671.shtml",
    "datetime": "2018-11-22 08:00:02",
    "code": "002940"
  },
  {
    "title": "次新股午后异动拉升 昂利康一度冲板",
    "href": "http://stock.jrj.com.cn/2018/11/12131325333011.shtml",
    "datetime": "2018-11-12 13:13:52",
    "code": "002940"
  },
  {
    "title": "昂利康成功上市助推“原料药与制剂双轮驱动”战略",
    "href": "http://stock.jrj.com.cn/ipo/2018/11/04092025300902.shtml",
    "datetime": "2018-11-04 09:20:56",
    "code": "002940"
  },
  {
    "title": "昂利康打开一字涨停 累计上涨108.06%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/30093025278371.shtml",
    "datetime": "2018-10-30 09:30:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]浙江昂利康制药股份有限公司实验中心及食堂项目环境影响评价信息公示",
    "href": "http://stock.jrj.com.cn/2018/10/26000025264976.shtml",
    "datetime": "2018-10-26 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]热烈庆祝浙江昂利康制药股份有限公司在深交所A股成功上市",
    "href": "http://stock.jrj.com.cn/2018/10/23000025246986.shtml",
    "datetime": "2018-10-23 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康10月23日上市定位分析",
    "href": "http://stock.jrj.com.cn/ipo/2018/10/22134325237736.shtml",
    "datetime": "2018-10-22 13:43:42",
    "code": "002940"
  },
  {
    "title": "昂利康：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/21212025232648.shtml",
    "datetime": "2018-10-21 21:20:00",
    "code": "002940"
  },
  {
    "title": "发红包了！昂利康中签号出炉 你中了吗？",
    "href": "http://stock.jrj.com.cn/2018/10/14174025199843.shtml",
    "datetime": "2018-10-14 17:40:04",
    "code": "002940"
  },
  {
    "title": "昂利康中签号码出炉 共40500个",
    "href": "http://stock.jrj.com.cn/ipo/2018/10/14165725199774.shtml",
    "datetime": "2018-10-14 16:57:20",
    "code": "002940"
  },
  {
    "title": "昂利康网上中签号出炉 共4.05万个",
    "href": "http://stock.jrj.com.cn/2018/10/14165525199770.shtml",
    "datetime": "2018-10-14 16:55:00",
    "code": "002940"
  },
  {
    "title": "昂利康：网上发行最终中签率为0.029%",
    "href": "http://stock.jrj.com.cn/2018/10/11203525189409.shtml",
    "datetime": "2018-10-11 20:35:00",
    "code": "002940"
  },
  {
    "title": "昂利康网上发行最终中签率0.0290%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/11203325189412.shtml",
    "datetime": "2018-10-11 20:33:00",
    "code": "002940"
  },
  {
    "title": "昂利康今日申购 顶格申购需配市值9万",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/11080325184595.shtml",
    "datetime": "2018-10-11 08:03:00",
    "code": "002940"
  },
  {
    "title": "新股提示：昂利康今日申购",
    "href": "http://stock.jrj.com.cn/2018/10/11072525184418.shtml",
    "datetime": "2018-10-11 07:25:00",
    "code": "002940"
  },
  {
    "title": "昂利康10月11日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2018/10/10140025181458.shtml",
    "datetime": "2018-10-10 14:00:27",
    "code": "002940"
  },
  {
    "title": "史上最低价券商股来了 但周四这只医药新股收益更可观",
    "href": "http://stock.jrj.com.cn/ipo/2018/10/09084725175365.shtml",
    "datetime": "2018-10-09 08:47:22",
    "code": "002940"
  },
  {
    "title": "昂利康IPO：重推广轻研发 两大推广服务商都是“自己人”",
    "href": "http://stock.jrj.com.cn/2018/09/05144725050640.shtml",
    "datetime": "2018-09-05 14:47:25",
    "code": "002940"
  },
  {
    "title": "[昂利康]省商务厅领导莅临我公司视察指导工作",
    "href": "http://stock.jrj.com.cn/2018/08/10000025138272.shtml",
    "datetime": "2018-08-10 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康制药等5公司首发申请将于7月17日上会",
    "href": "http://stock.jrj.com.cn/2018/07/13202224814378.shtml",
    "datetime": "2018-07-13 20:22:00",
    "code": "002940"
  },
  {
    "title": "昂利康制药IPO:曾涉嫌数据造假 报告期内遭遇安全生产事故",
    "href": "http://stock.jrj.com.cn/ipo/2018/04/16113424394299.shtml",
    "datetime": "2018-04-16 11:34:00",
    "code": "002940"
  },
  {
    "title": "浙江昂利康制药股份有限公司首次公开发行股票招股说明书（申报稿2018年3月30日报送）",
    "href": "http://stock.jrj.com.cn/ipo/2018/04/13223024388976.shtml",
    "datetime": "2018-04-13 22:30:10",
    "code": "002940"
  },
  {
    "title": "[昂利康]2018年昂利康数据完整性及验证培训圆满结束",
    "href": "http://stock.jrj.com.cn/2018/01/24000025138278.shtml",
    "datetime": "2018-01-24 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]嵊州市国税局人员来我公司指导党建工作",
    "href": "http://stock.jrj.com.cn/2018/01/12000025138277.shtml",
    "datetime": "2018-01-12 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]公司与Intertek天翔集团就欧盟GMP认证咨询项目建立合作关系",
    "href": "http://stock.jrj.com.cn/2017/12/25000025138267.shtml",
    "datetime": "2017-12-25 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]绍兴市人力社保局副局长来访我公司",
    "href": "http://stock.jrj.com.cn/2017/12/25000025138276.shtml",
    "datetime": "2017-12-25 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]2017年嵊州市消防重点化工企业会议",
    "href": "http://stock.jrj.com.cn/2017/11/24000025138274.shtml",
    "datetime": "2017-11-24 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]公司参展2017年厦门药展会",
    "href": "http://stock.jrj.com.cn/2017/11/17000025138275.shtml",
    "datetime": "2017-11-17 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]绍兴市副市长来我公司督查安全生产工作",
    "href": "http://stock.jrj.com.cn/2017/09/19000025138273.shtml",
    "datetime": "2017-09-19 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]2017年嵊州市危险化学品事故应急演练",
    "href": "http://stock.jrj.com.cn/2017/07/25000025138271.shtml",
    "datetime": "2017-07-25 00:00:00",
    "code": "002940"
  },
  {
    "title": "昂利康制药闯关A股:负债率居高不下 三年环保支出近6000万",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/04115322694049.shtml",
    "datetime": "2017-07-04 11:53:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]公司参展2017年上海药展会",
    "href": "http://stock.jrj.com.cn/2017/06/22000025138270.shtml",
    "datetime": "2017-06-22 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]绍兴市组织部长来我公司调研人才相关工作",
    "href": "http://stock.jrj.com.cn/2017/06/02000025138269.shtml",
    "datetime": "2017-06-02 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]绍兴市委副书记、市长莅临公司调研",
    "href": "http://stock.jrj.com.cn/2017/05/24000025138268.shtml",
    "datetime": "2017-05-24 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]体现企业责任 弘扬博爱精神",
    "href": "http://stock.jrj.com.cn/2017/04/18000025138281.shtml",
    "datetime": "2017-04-18 00:00:00",
    "code": "002940"
  },
  {
    "title": "[昂利康]荣获浙江省嵊州市2016年度工业企业30强第一名",
    "href": "http://stock.jrj.com.cn/2017/02/06000025138280.shtml",
    "datetime": "2017-02-06 00:00:00",
    "code": "002940"
  }
]